Form 8-K ANI PHARMACEUTICALS INC For: Aug 01
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
ANI Pharmaceuticals (ANIP) Posts Q2 Loss of 21c/Share
August 4, 2014 8:36 AM EDTANI Pharmaceuticals (NASDAQ: ANIP) reported Q2 EPS of ($0.21), which may not compare with the analyst estimate of $0.01. Revenue for the quarter came in at $6.6 million versus the consensus estimate of $7.95 million.
Adjusted non-GAAP EBITDA was $0.2 million for the three months ended June 30, 2014,... More
